LAUREN STEPHAN: Open Payments
NPI 1902526353 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 32 payments from 8 companies in 2025. Trend: 2023 $2,928 · 2024 $3,605 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $316 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $168 |
| Otsuka America Pharmaceutical, Inc. | 3 | $135 |
| Axsome Therapeutics, Inc. | 2 | $135 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Corium, LLC | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Auvelity, COBENFY, HETLIOZ, Azstarys.
Industry payments across SC — which companies pay providers there.
